应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00858 精优药业
休市中 02-06 15:36:05
0.083
+0.001
+1.22%
最高
0.095
最低
0.083
成交量
240.00万
今开
0.084
昨收
0.082
日振幅
14.63%
总市值
2.12亿
流通市值
2.12亿
总股本
25.50亿
成交额
21.14万
换手率
0.09%
流通股本
25.50亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
精优药业盘中异动 早盘股价大涨6.25%
市场透视 · 02-04
精优药业盘中异动 早盘股价大涨6.25%
精优药业(00858)披露2026年1月股份变动月报,股本维持稳定
公告速递 · 02-03
精优药业(00858)披露2026年1月股份变动月报,股本维持稳定
精优药业盘中异动 大幅下跌5.00%报0.076港元
市场透视 · 01-29
精优药业盘中异动 大幅下跌5.00%报0.076港元
【招商传媒】AI应用研究感思录(一):专业数据公司有望迎来重估
招商传媒研究 · 01-24
【招商传媒】AI应用研究感思录(一):专业数据公司有望迎来重估
精优药业盘中异动 股价大跌5.26%
市场透视 · 01-21
精优药业盘中异动 股价大跌5.26%
精优药业(00858):杨晓蓉获委任为独立非执行董事
智通财经 · 01-20
精优药业(00858):杨晓蓉获委任为独立非执行董事
精优药业盘中异动 临近收盘急速跳水5.15%报0.092港元
市场透视 · 01-16
精优药业盘中异动 临近收盘急速跳水5.15%报0.092港元
精优药业01月15日主力净流出30万元 散户资金买入
市场透视 · 01-15
精优药业01月15日主力净流出30万元 散户资金买入
精优药业盘中异动 股价大涨6.74%报0.095港元
市场透视 · 01-13
精优药业盘中异动 股价大涨6.74%报0.095港元
精优药业盘中异动 下午盘急速拉升6.10%
市场透视 · 01-05
精优药业盘中异动 下午盘急速拉升6.10%
精优药业盘中异动 股价大跌7.95%
市场透视 · 2025-12-31
精优药业盘中异动 股价大跌7.95%
精优药业(00858)附属长春精优拟向长春市韩都鼎业房地产策划销售有限公司回购长春精优约10.06%股权
智通财经 · 2025-12-30
精优药业(00858)附属长春精优拟向长春市韩都鼎业房地产策划销售有限公司回购长春精优约10.06%股权
精优药业(00858):郭懿获委任为行政总裁
智通财经 · 2025-12-30
精优药业(00858):郭懿获委任为行政总裁
精优药业授出合共7650万份购股权
新浪港股 · 2025-12-22
精优药业授出合共7650万份购股权
精优药业(00858)授出合共7650万份购股权
智通财经 · 2025-12-19
精优药业(00858)授出合共7650万份购股权
精优药业盘中异动 下午盘股价大跌6.45%报0.087港元
市场透视 · 2025-12-18
精优药业盘中异动 下午盘股价大跌6.45%报0.087港元
港股综述 | 科指跌近2%,华虹半导体跌超5%;中国中冶重挫21%,歌礼制药-B飙升18%
老虎资讯综合 · 2025-12-09
港股综述 | 科指跌近2%,华虹半导体跌超5%;中国中冶重挫21%,歌礼制药-B飙升18%
精优药业控股(00858)2025年11月股份变动月报:股本维持不变
公告速递 · 2025-12-03
精优药业控股(00858)2025年11月股份变动月报:股本维持不变
精优药业(00858)发布中期业绩 股东应占亏损4.6亿港元 同比盈转亏
智通财经 · 2025-11-28
精优药业(00858)发布中期业绩 股东应占亏损4.6亿港元 同比盈转亏
精优药业控股有限公司2025财年中期营收2800万港元,净亏损4.59亿港元
公告速递 · 2025-11-28
精优药业控股有限公司2025财年中期营收2800万港元,净亏损4.59亿港元
加载更多
公司概况
公司名称:
精优药业
所属市场:
SEHK
上市日期:
--
主营业务:
精优药业控股有限公司是一家主要从事开发、制造及销售药品的投资控股公司。该公司主要通过三个分部运营业务。制造分部从事医药产品的开发、制造及销售业务。其自制产品包括转移因子口服溶液、贯新克及洲邦等。贸易分部从事进口药品的推广及经销业务。其进口产品包括美利巴及适今可。基因开发分部从事基因相关技术的商业开发及研发业务。
发行价格:
--
{"stockData":{"symbol":"00858","market":"HK","secType":"STK","nameCN":"精优药业","latestPrice":0.083,"timestamp":1770363365288,"preClose":0.082,"halted":0,"volume":2400000,"delay":0,"changeRate":0.012195121951219523,"floatShares":2550000000,"shares":2550000000,"eps":0.074333,"marketStatus":"休市中","change":0.001,"latestTime":"02-06 15:36:05","open":0.084,"high":0.095,"low":0.083,"amount":211370,"amplitude":0.146341,"askPrice":0.089,"askSize":10000,"bidPrice":0.083,"bidSize":150000,"shortable":0,"etf":0,"ttmEps":-0.133,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":7,"adr":0,"listingDate":920995200000,"exchange":"SEHK","adjPreClose":0.082,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":1.2158054710876656,"lotSize":10000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00858","defaultTab":"news","newsList":[{"id":"2608963398","title":"精优药业盘中异动 早盘股价大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608963398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608963398?lang=zh_cn&edition=full","pubTime":"2026-02-04 10:04","pubTimestamp":1770170673,"startTime":"0","endTime":"0","summary":"2026年02月04日早盘10时04分,精优药业股票出现波动,股价快速拉升6.25%。截至发稿,该股报0.085港元/股,成交量92万股,换手率0.04%,振幅6.25%。精优药业股票所在的药品行业中,整体跌幅为0.56%。其相关个股中,君圣泰医药-B、精优药业、劲方医药-B涨幅较大,振幅较大的相关个股有德琪医药-B、英硅智能、海王英特龙,振幅分别为8.23%、7.46%、4.73%。精优药业公司简介:精优药业控股有限公司是一家主要从事开发、制造及销售药品的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204100433953fb5ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204100433953fb5ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00858","BK1191"],"gpt_icon":0},{"id":"1132676330","title":"精优药业(00858)披露2026年1月股份变动月报,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1132676330","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132676330?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:46","pubTimestamp":1770108395,"startTime":"0","endTime":"0","summary":"精优药业控股有限公司于2026年2月3日公布了截至2026年1月31日的股份变动月报。2026年1月内,公司已发行普通股数目维持在2,550,000,000股,未见新增发行或回购注销活动。在股权激励方面,公司2022年9月2日采纳的购股权计划本月底未产生行使行为。截至报告期末,购股权数量保持在76,500,000份,对应可能发行或转让的股份数目为162,500,000股。公司同时确认截至2026年1月31日,满足香港联交所上市规则规定的最低公众持股量要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00858"],"gpt_icon":0},{"id":"2607477082","title":"精优药业盘中异动 大幅下跌5.00%报0.076港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607477082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607477082?lang=zh_cn&edition=full","pubTime":"2026-01-29 09:43","pubTimestamp":1769651024,"startTime":"0","endTime":"0","summary":"2026年01月29日早盘09时43分,精优药业股票出现异动,股价大幅下挫5.00%。截至发稿,该股报0.076港元/股,成交量23万股,换手率0.01%,振幅5.00%。资金方面,该股资金流入0港元,流出1.4万港元。精优药业股票所在的药品行业中,整体涨幅为0.06%。其相关个股中,英硅智能、开拓药业-B、凯莱英涨幅较大,振幅较大的相关个股有英硅智能、君圣泰医药-B、开拓药业-B,振幅分别为8.54%、7.61%、5.84%。贸易分部从事进口药品的推广及经销业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129094344a6b95b2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129094344a6b95b2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00858"],"gpt_icon":0},{"id":"2606231684","title":"【招商传媒】AI应用研究感思录(一):专业数据公司有望迎来重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2606231684","media":"招商传媒研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606231684?lang=zh_cn&edition=full","pubTime":"2026-01-24 22:47","pubTimestamp":1769266048,"startTime":"0","endTime":"0","summary":"专业数据公司有望迎来重近期阿里千问做出重大更新,整合了淘宝,飞猪,支付宝等,AI大模型超级入口之争迎来关键时刻。本公司具有中国证监会许可的证券投资咨询业务资格。客户应当考虑到本公司可能存在可能影响本报告客观性的利益冲突。本报告版权归本公司所有。本公司保留所有权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124232445953e319e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124232445953e319e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00858","600633","003010","09988","603000","SG9999001069.SGD","BK1618","BK1128","LU2097828805.USD","LU2097828474.EUR","LU2097828714.EUR","09626","301110","BK1104","TAL","EDU","BK1615","SG9999003461.SGD","SG9999006597.SGD","300785","BABA","BK1095","IE0034224299.USD","300010","603888","LU2097828631.EUR","SG9999001051.SGD","002599","BK1588","SG9999001093.SGD","09901","BK1608","BK1575","LU2097828557.USD","BK1587"],"gpt_icon":1},{"id":"2605839214","title":"精优药业盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605839214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605839214?lang=zh_cn&edition=full","pubTime":"2026-01-21 14:18","pubTimestamp":1768976289,"startTime":"0","endTime":"0","summary":"2026年01月21日下午盘14时18分,精优药业股票出现波动,股价大幅下跌5.26%。截至发稿,该股报0.090港元/股,成交量23万股,换手率0.01%,振幅1.05%。精优药业股票所在的药品行业中,整体跌幅为0.08%。其相关个股中,开拓药业-B、英硅智能、泰凌医药涨幅较大,振幅较大的相关个股有开拓药业-B、海西新药、康龙化成,振幅分别为9.09%、8.86%、6.57%。精优药业公司简介:精优药业控股有限公司是一家主要从事开发、制造及销售药品的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012114180997a2b57d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012114180997a2b57d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00858"],"gpt_icon":0},{"id":"2604116845","title":"精优药业(00858):杨晓蓉获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2604116845","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604116845?lang=zh_cn&edition=full","pubTime":"2026-01-20 21:34","pubTimestamp":1768916071,"startTime":"0","endTime":"0","summary":"智通财经APP讯,精优药业 发布公告,自2026年1月20日起,方林虎先生,由于年事已高,并为能将更多时间投入家庭事务,已辞任独立非执行董事、本公司审核委员会及薪酬委员会主席以及本公司提名委员会成员职务。董事会进一步宣布,自2026年1月20日起,杨晓蓉女士获委任为独立非执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00858"],"gpt_icon":0},{"id":"2604905369","title":"精优药业盘中异动 临近收盘急速跳水5.15%报0.092港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604905369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604905369?lang=zh_cn&edition=full","pubTime":"2026-01-16 15:58","pubTimestamp":1768550304,"startTime":"0","endTime":"0","summary":"2026年01月16日临近收盘15时58分,精优药业股票出现波动,股价急速下挫5.15%。截至发稿,该股报0.092港元/股,成交量377万股,换手率0.15%,振幅8.25%。资金方面,该股资金流入23.943万港元,流出9.706万港元。最近的财报数据显示,该股实现营业收入2,800.80万港元,净利润-4.60亿港元,每股收益-0.19港元,毛利1,227.00万港元,市盈率1.05倍。精优药业股票所在的药品行业中,整体跌幅为0.17%。贸易分部从事进口药品的推广及经销业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011615582497a21415&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011615582497a21415&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00858"],"gpt_icon":0},{"id":"2603573229","title":"精优药业01月15日主力净流出30万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2603573229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603573229?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:15","pubTimestamp":1768464918,"startTime":"0","endTime":"0","summary":"01月15日, 精优药业股价跌5.83%,报收0.10元,成交金额72.7万元,换手率0.29%,振幅10.68%,量比1.97。精优药业今日主力资金净流出30万元,上一交易日主力净流出0万元。该股近5个交易日上涨10.00%,主力资金累计净流出10.7万元;近20日主力资金累计净流出10.7万元,其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115161633a4c6b748&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115161633a4c6b748&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00858","BK1191"],"gpt_icon":0},{"id":"2603688919","title":"精优药业盘中异动 股价大涨6.74%报0.095港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603688919?lang=zh_cn&edition=full","pubTime":"2026-01-13 13:20","pubTimestamp":1768281644,"startTime":"0","endTime":"0","summary":"2026年01月13日下午盘13时20分,精优药业股票出现异动,股价急速上涨6.74%。截至发稿,该股报0.095港元/股,成交量394万股,换手率0.15%,振幅7.87%。资金方面,该股资金流入27.708万港元,流出7.82万港元。精优药业股票所在的药品行业中,整体涨幅为1.19%。其相关个股中,三爱健康集团、精优药业、华控康泰涨幅较大,振幅较大的相关个股有三爱健康集团、华控康泰、英硅智能,振幅分别为17.00%、13.33%、9.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011313204597a18f81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011313204597a18f81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00858","BK1191"],"gpt_icon":0},{"id":"2601005455","title":"精优药业盘中异动 下午盘急速拉升6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601005455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601005455?lang=zh_cn&edition=full","pubTime":"2026-01-05 14:46","pubTimestamp":1767595609,"startTime":"0","endTime":"0","summary":"2026年01月05日下午盘14时46分,精优药业股票出现异动,股价急速上涨6.10%。截至发稿,该股报0.087港元/股,成交量74万股,换手率0.03%,振幅7.32%。精优药业股票所在的药品行业中,整体涨幅为1.44%。其相关个股中,中智药业、中国同辐、信达生物涨幅较大,振幅较大的相关个股有中智药业、宝济药业-B、三爱健康集团,振幅分别为30.00%、15.71%、13.00%。贸易分部从事进口药品的推广及经销业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105144649a6f4b385&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105144649a6f4b385&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00858","BK1191"],"gpt_icon":0},{"id":"2600709221","title":"精优药业盘中异动 股价大跌7.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600709221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600709221?lang=zh_cn&edition=full","pubTime":"2025-12-31 10:24","pubTimestamp":1767147886,"startTime":"0","endTime":"0","summary":"2025年12月31日早盘10时24分,精优药业股票出现波动,股价大幅下跌7.95%。截至发稿,该股报0.081港元/股,成交量10万股,换手率0.00%,振幅0.00%。精优药业股票所在的药品行业中,整体跌幅为0.31%。其相关个股中,英硅智能、海王英特龙、中智药业涨幅较大,振幅较大的相关个股有英硅智能、中智药业、兆科眼科-B,振幅分别为8.94%、7.41%、5.19%。精优药业公司简介:精优药业控股有限公司是一家主要从事开发、制造及销售药品的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231102446a6e38005&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231102446a6e38005&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00858"],"gpt_icon":0},{"id":"2595790897","title":"精优药业(00858)附属长春精优拟向长春市韩都鼎业房地产策划销售有限公司回购长春精优约10.06%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2595790897","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595790897?lang=zh_cn&edition=full","pubTime":"2025-12-30 21:33","pubTimestamp":1767101591,"startTime":"0","endTime":"0","summary":"智通财经APP讯,精优药业 公布,于2025年12月30日,长春精优拟向长春市韩都鼎业房地产策划销售有限公司回购长春精优约10.06%股权,代价为人民币440万元。于股份回购完成后,回购股份将予注销,而股东于长春精优的持股比例于股份注销后将按比例增加,因此集团于长春精优的股权将增加至89.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1148","00858","09979","BK1191"],"gpt_icon":0},{"id":"2595179446","title":"精优药业(00858):郭懿获委任为行政总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2595179446","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595179446?lang=zh_cn&edition=full","pubTime":"2025-12-30 20:12","pubTimestamp":1767096733,"startTime":"0","endTime":"0","summary":"智通财经APP讯,精优药业(00858)发布公告,为达致职责分工、满足公司发展需要及提升企业管治水平,自2026年1月1日起:(1)谢毅博士将辞任公司行政总裁,以便专注于制定公司策略。谢博士于辞任行政总裁后将继续担任董事会主席及执行董事;及(2)执行董事郭懿博士将获委任为行政总裁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"精优药业(00858):郭懿获委任为行政总裁","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00858"],"gpt_icon":0},{"id":"2593117140","title":"精优药业授出合共7650万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2593117140","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593117140?lang=zh_cn&edition=full","pubTime":"2025-12-22 08:50","pubTimestamp":1766364600,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 精优药业(00858)发布公告,于2025年12月19日,公司根据其于2022年9月2日采纳的购股权计划,向合共3名承授人(即程勇先生、楼屹博士及郭懿博士,彼等均为执行董事)提呈授出合共7650万份购股权。购股权的行使价为每股0.0936港元。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-12-22/doc-inhcrpzt8052474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00858","BK1191"],"gpt_icon":0},{"id":"2592167519","title":"精优药业(00858)授出合共7650万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2592167519","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592167519?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:32","pubTimestamp":1766151120,"startTime":"0","endTime":"0","summary":"智通财经APP讯,精优药业(00858)发布公告,于2025年12月19日,公司根据其于2022年9月2日采纳的购股权计划,向合共3名承授人(即程勇先生、楼屹博士及郭懿博士,彼等均为执行董事)提呈授出合共7650万份购股权。购股权的行使价为每股0.0936港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383991.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00858"],"gpt_icon":0},{"id":"2592136524","title":"精优药业盘中异动 下午盘股价大跌6.45%报0.087港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592136524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592136524?lang=zh_cn&edition=full","pubTime":"2025-12-18 13:02","pubTimestamp":1766034122,"startTime":"0","endTime":"0","summary":"2025年12月18日下午盘13时02分,精优药业股票出现异动,股价大幅跳水6.45%。截至发稿,该股报0.087港元/股,成交量171万股,换手率0.07%,振幅3.23%。资金方面,该股资金流入9.268万港元,流出5.978万港元。精优药业股票所在的药品行业中,整体涨幅为0.13%。其相关个股中,天大药业、石药集团、泰凌医药涨幅较大,振幅较大的相关个股有石药集团、宝济药业-B、中智药业,振幅分别为7.18%、6.09%、5.36%。贸易分部从事进口药品的推广及经销业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121813020297a07391&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121813020297a07391&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00858","BK1191"],"gpt_icon":0},{"id":"1135642945","title":"港股综述 | 科指跌近2%,华虹半导体跌超5%;中国中冶重挫21%,歌礼制药-B飙升18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135642945","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135642945?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:40","pubTimestamp":1765269633,"startTime":"0","endTime":"0","summary":"港股行情港股三大指数齐跌, 恒生指数跌1.29%,恒生科技指数跌1.90%,国企指数跌1.62%。半导体股普跌,$华虹半导体$跌超5%,$中芯国际$跌超4%,$英诺赛科$跌超3%,$上海复旦$跌超1%。保险股普跌,$中国人民保险集团$跌超5%,$中国人寿$跌超4%,$中国平安$跌超3%。个股方面:中国中冶重挫21%,拟607亿元出售中冶置业、中冶铜锌等资产。","market":"us","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"533662008f8bae61a0f8ee387a7d2916","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00858","02068","HSI","HSTECH","00981","03993","BK4153","01618","06693","02600","00690"],"gpt_icon":0},{"id":"1158012027","title":"精优药业控股(00858)2025年11月股份变动月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1158012027","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158012027?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:37","pubTimestamp":1764751053,"startTime":"0","endTime":"0","summary":"精优药业控股有限公司于2025年12月3日发布2025年11月股份变动月报表。报告期为截至2025年11月30日,公司注册股本维持在20,000,000,000股,面值每股0.01港元,总额2亿港元。已发行股份亦保持在2,550,000,000股,报告期内未有新增发行、回购、注销或库藏股变动。公告由执行董事及公司秘书王秀娟签署,公司确认已遵守香港联交所《上市规则》及相关法律法规的要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00858"],"gpt_icon":0},{"id":"2586735118","title":"精优药业(00858)发布中期业绩 股东应占亏损4.6亿港元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2586735118","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586735118?lang=zh_cn&edition=full","pubTime":"2025-11-28 23:12","pubTimestamp":1764342733,"startTime":"0","endTime":"0","summary":"智通财经APP讯,精优药业(00858)发布截至2025年9月30日止六个月中期业绩,收益2800.8万港元,同比减少9.04%;股东应占亏损4.6亿港元,同比盈转亏;每股亏损19.09港仙。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"精优药业(00858)发布中期业绩 股东应占亏损4.6亿港元 同比盈转亏","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00858","BK1191"],"gpt_icon":0},{"id":"1177706542","title":"精优药业控股有限公司2025财年中期营收2800万港元,净亏损4.59亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177706542","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177706542?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:51","pubTimestamp":1764341469,"startTime":"0","endTime":"0","summary":"截至2025年9月30日止六个月,精优药业控股有限公司录得营收约2800万港元,同比上一财年同期下降约9%。同期净亏损约为4.59亿港元,而上年同期则实现净利润约1.01亿港元。毛利约为1227万港元,对应毛利率约43.8%,高于上年同期的38.4%。制造业务方面,期内营收约2800万港元,同比减少约280万港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00858"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.extrawell.com.hk","stockEarnings":[{"period":"1week","weight":0.0506},{"period":"1month","weight":-0.0778},{"period":"3month","weight":-0.0674},{"period":"6month","weight":-0.3083},{"period":"1year","weight":0.7292},{"period":"ytd","weight":0.0122}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.2713},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"精优药业控股有限公司是一家主要从事开发、制造及销售药品的投资控股公司。该公司主要通过三个分部运营业务。制造分部从事医药产品的开发、制造及销售业务。其自制产品包括转移因子口服溶液、贯新克及洲邦等。贸易分部从事进口药品的推广及经销业务。其进口产品包括美利巴及适今可。基因开发分部从事基因相关技术的商业开发及研发业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.407407,"avgChangeRate":0.054952},{"month":2,"riseRate":0.518519,"avgChangeRate":0.029766},{"month":3,"riseRate":0.307692,"avgChangeRate":0.033102},{"month":4,"riseRate":0.333333,"avgChangeRate":0.015335},{"month":5,"riseRate":0.37037,"avgChangeRate":0.093567},{"month":6,"riseRate":0.407407,"avgChangeRate":0.067885},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.047459},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.038636},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.023131},{"month":10,"riseRate":0.333333,"avgChangeRate":0.010027},{"month":11,"riseRate":0.423077,"avgChangeRate":0.02567},{"month":12,"riseRate":0.296296,"avgChangeRate":-0.022304}],"exchange":"SEHK","name":"精优药业","nameEN":"EXTRAWELL PHAR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"精优药业(00858)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供精优药业(00858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"精优药业,00858,精优药业股票,精优药业股票老虎,精优药业股票老虎国际,精优药业行情,精优药业股票行情,精优药业股价,精优药业股市,精优药业股票价格,精优药业股票交易,精优药业股票购买,精优药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"精优药业(00858)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供精优药业(00858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}